Negócios · 23/06/20161 min de leitura
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Amendment of Notice
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. This meeting was announced in the Federal Register of June 16, 2016. The amendment is being made to reflect a change in the Procedure portion of the document. There are no other changes.